Abcam plc
ABCM
Pozycja w akcjach
#3475
Abcam plc operates as a prominent life science enterprise, dedicated to the... Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in supporting diverse scientific investigations, diagnostic applications, and the advancement of pharmaceutical drug discovery initiatives. Its comprehensive product portfolio features primary and secondary antibodies, conjugated antibodies paired with their respective kits, both singleplex and multiplex immunoassays, as well as a variety of proteins and peptides, including cytokines. Furthermore, the company provides edited cell lines, lysates, cellular activity kits, miRNA kits, biochemical compounds, and specialized tools for analyzing cell signaling pathways. Abcam serves a broad customer base, encompassing researchers and scientists within academic and institutional environments, alongside professionals at pharmaceutical, biotechnology, and diagnostic companies. The company boasts a global presence, conducting operations across the Americas, Europe, the Middle East, Africa, China, Japan, and the wider Asia Pacific region. Product distribution is primarily facilitated via its online platform. Founded in 1998, Abcam plc is headquartered in Cambridge, United Kingdom.
Cena akcji
$23.99
Ostatnia synchronizacja: 2023-12-15
Kapitalizacja rynkowa
$4.90B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel Abcam plc (ABCM)
Kategoria
Healthcare
Historia ceny akcji dla Abcam plc (ABCM)
Najwyższa cena zamknięcia: $23.99 dnia 2023-12-01
Najniższa cena zamknięcia: $5.03 dnia 2010-12-01
Najniższa cena zamknięcia: $5.03 dnia 2010-12-01
Historia cen akcji firmy Abcam plc od 2010 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2023 | 52.62% |
| 2022 | -30.63% |
| 2021 | 14.63% |
| 2020 | 7.37% |
| 2019 | 36.13% |
| 2018 | 0.50% |
| 2017 | 36.16% |
| 2016 | 11.41% |
| 2015 | 34.09% |
| 2014 | -11.33% |
| 2013 | 25.46% |
| 2012 | 29.04% |
| 2011 | -8.40% |
| 2010 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.73 | -3.85% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
